Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Viktravi

- PMLiVE

ABPI hits out at ‘punitive’ UK medicines cost controls

Steep rise in charges an 'alarming signal' amid Brexit uncertainty

- PMLiVE

UK unveils plans for bigger medicines price squeeze

Company payments to government would rise steeply to 2021

- PMLiVE

Daily Brief: Theresa May and the diabetes sensor, Biosimilars hit Roche in Europe, Gilead CEO to step down

News from pharma, biotech and healthcare

- PMLiVE

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

News from pharma, biotech and healthcare

- PMLiVE

Daily Brief: Trump arrives in London, NICE says no to Darzalex, Pfizer backs down on prices

The latest from pharma, biotech and healthcare

- PMLiVE

Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’

CEO writes open letter to prime minister

- PMLiVE

NHS England says yes to Roche’s Hemlibra

But stalls on funding for Actelion's Uptravi

- PMLiVE

Axovant licenses another gene therapy as new strategy beds in

Group pursues gene therapy strategy

- PMLiVE

Vertex calls NHS England ‘outrageous’ as Orkambi talks stall again

Public row about confidential pricing talks drags on

- PMLiVE

The NHS at 70: celebrations, renewed reforms and difficult choices

Health service remains popular with public, but faces daunting need for radical change

- PMLiVE

Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched

The latest from pharma, biotech and healthcare

- PMLiVE

Daily Brief: Andrew Witty’s replacement on Accelerated Access initiative, Blincyto gains full EU approval and more

The latest news from across pharma, biotech and healthcare

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links